| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.0088 | 0.9 |